Search
SRT-1720
go.drugbank.com/drugs/DB17057ExperimentalSRT-1720 is an activator of NAD(+)-dependent histone deacetylase SIRT1.[A253147]
Bepranemab
go.drugbank.com/drugs/DB17945InvestigationalBepranemab is a recombinant humanized Igg4P monoclonal antibody directed against human Tau.
Synonyms: Immunoglobulin g4 (226-proline), anti-(human tau protein) (human-rattus norvegicus monoclonal ucb0107 .gamma.4-chain), disulfide with human-rattus norvegicus monoclonal ucb0107 .kappa.-chain, dimerEdralbrutinib
go.drugbank.com/drugs/DB18095InvestigationalEdralbrutinib is an orally available small molecule inhibitor of Bruton's tyrosine kinase.
Synonyms: 4-amino-3-(4-(2,6-difluorophenoxy)phenyl)-1,6-dihydro-1-((3r)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-7h-pyrrolo(2,3-d)pyridazin-7-one, 7h-pyrrolo(2,3-d)pyridazin-7-one, 4-amino-3-(4-(2,6-difluorophenoxy)phenyl)-1,6-dihydro-1-((3r)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-VCN-01
go.drugbank.com/drugs/DB18193InvestigationalVCN-01 is an investigational, genetically modified human adenovirus encoding human PH20.
Acediasulfone
go.drugbank.com/drugs/DB08926ExperimentalAcediasulfone (INN) is an antimicrobial and antimalarial long-acting prodrug of dapsone.
Bicifadine
go.drugbank.com/drugs/DB04889InvestigationalBicifadine (DOV-220075) is a nonopioid analgesic. It is an inhibitor of both the norepinephrine and serotonin transporters and an NMDA antagonist with a non-narcotic profile.
Categories: Monoamine Oxidase A SubstratesCarbon black
go.drugbank.com/drugs/DB11980InvestigationalProduced by the incomplete combustion of hydrocarbons, carbon black is an insoluble pigment [A263396] with demonstrated adverse effects on pulmonary function. … [A263401] Upon inhalation, carbon black has been reported to trigger an inflammatory response in the lung tissue [A263401] and has been linked to carcinogenicity.[A263406, A263411, A263416]
Synonyms: DC BLACK NO. 2, D&C black no. 2AMT-080
go.drugbank.com/drugs/DB17846ExperimentalAMT-080 is an investigational gene therapy being investigated for the treatment of Duchenne muscular dystrophy.
CTX130
go.drugbank.com/drugs/DB18627InvestigationalCTX130 is an allogeneic CRISPR/Cas9-mediated genetically modified CAR T cell therapy targeting CD70 antigen.
AG-24322
go.drugbank.com/drugs/DB13035InvestigationalAG-024322 has been used in trials studying the treatment of Neoplasms and Lymphoma, Non-Hodgkin.